Skip to main content
. Author manuscript; available in PMC: 2018 Apr 1.
Published in final edited form as: Exerc Sport Sci Rev. 2017 Apr;45(2):116–123. doi: 10.1249/JES.0000000000000104

Figure 2.

Figure 2

Endothelial function measured via brachial artery flow-mediated dilation (FMD) before and after 12 weeks of placebo, or oral or transdermal estradiol treatment, and an additional 12 weeks of placebo or estradiol treatment plus aerobic exercise training. *P<0.01 vs baseline; † P<0.01 vs. 12 weeks; ‡P<0.01 vs placebo 12 weeks. (Reprinted from (25). Copyright 2013 Endocrine Society. Used with permission.)